Related Experiment Video
Updated: May 13, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
Renal artery stenosis predicts coronary artery disease in patients with hypertension
Thiago A Macedo1, Rodrigo P Pedrosa, Valeria Costa-Hong
1Hypertension Unit, Cardiology Division, Heart Institute (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. thiago.cardio@gmail.com
Insights
In hypertensive patients undergoing renal angiography, severe renal artery stenosis (RAS) is a strong predictor of severe coronary artery disease (CAD), even without angina symptoms. This suggests considering simultaneous investigation for both conditions.
Area of Science:
- Cardiology
- Nephrology
- Vascular Medicine
Background:
- Hypertension management often requires renal arteriography to diagnose renal artery stenosis (RAS).
- Predictors and frequency of concurrent coronary artery disease (CAD) in hypertensive patients with RAS are not well-defined.
- Current guidelines lack recommendations for investigating CAD in patients with RAS.
Purpose of the Study:
- To determine the frequency of CAD in hypertensive patients undergoing renal angiography.
- To identify predictors of CAD in this patient population.
- To evaluate the association between RAS and CAD.
Main Methods:
- Eighty-two hypertensive patients with suspected RAS underwent simultaneous renal and coronary angiography.
- Significant stenosis was defined as ≥ 70% obstruction in either territory.
- Logistic regression analysis was used to identify independent predictors of CAD.
Main Results:
- Significant CAD was present in 39% of patients, and significant RAS in 39%.
- Both significant CAD and RAS were found in 25.6% of patients.
- RAS ≥ 70% was independently associated with CAD ≥ 70% (OR: 11.48), irrespective of angina symptoms.
Conclusions:
- Severe RAS is a strong predictor of severe CAD in hypertensive patients referred for renal angiography.
- Simultaneous investigation for CAD should be considered in these patients.
- RAS may be an independent marker for CAD, even in the absence of angina.
Abstract:
In hypertensive patients with indication of renal arteriography to investigate renal artery stenosis (RAS) there are no recommendations regarding when to investigate coronary artery disease (CAD). Moreover, the predictors of CAD in patients with RAS are not clear. We aimed to evaluate the frequency and the determinants of CAD in hypertensive patients referred to renal angiography. Eighty-two consecutive patients with high clinical risk suggesting the presence of RAS systematically underwent renal angiography and coronary angiography during the same procedure. Significant arterial stenosis was defined by an obstruction ≥ 70% to both renal and coronary territories. Significant CAD was present in 32/82 (39%) and significant RAS in 32/82 (39%) patients. Both CAD and RAS were present in 25.6% from the 82 patients. Patients with severe CAD were older (63 ± 12 vs. 56 ± 13 years; p = 0.03) and had more angina (41 vs. 16%; p = 0.013) compared to patients without severe CAD. Significant RAS was associated with an increased frequency of severe CAD compared to patients without significant RAS (66% vs. 22%, respectively; p<0.001). Myocardial scintigraphy showed ischemia in 21.8% of the patients with CAD. Binary logistic regression analysis showed that RAS ≥ 70% was independently associated with CAD ≥ 70% (OR: 11.48; 95% CI 3.2-40.2; p<0.001), even in patients without angina (OR: 13.48; 95%CI 2.6-12.1; p<0.001). Even considering a small number of patients with significant RAS, we conclude that in hypertensive patients referred to renal angiography, RAS ≥ 70% may be a strong predictor of severe CAD, independently of angina, and dual investigation should be considered.
Related Concept Videos
Hypertension II: Pathophysiology
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Antihypertensive Drugs: Direct Renin Inhibitors
